Komori
Governance4528ONO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Regarding the Introduction of a Long-Term Incentive Stock Compensation Plan for Employees of U.S. Subsidiary Deciphera Pharmaceuticals, Inc.

The company will newly introduce a long-term incentive plan using its shares for employees of its U.S. subsidiary, Deciphera Pharmaceuticals, Inc. In connection with the introduction of the plan, it will dispose of 8,398,300 treasury shares, valued at ¥20,454 million, to an ESOP trust.

Worth reading
50Recurring
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
20454
¥ million
Wording
Definitive
How definitive the wording is.

Contents of this filing

Changes this time

米国子会社Deciphera社従業員向けの長期インセンティブ株式報酬制度を導入し、自己株式8,398,300株(20,454百万円)をESOP信託に処分することを決議。

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this time米国子会社Deciphera社従業員向けの長期インセンティブ株式報酬制度を導入し、自己株式8,398,300株(20,454百万円)をESOP信託に処分することを決議。
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Deciphera社従業員のエンゲージメント向上と、中長期的な企業価値向上への意識強化を図るため。また、株価を意識した業務遂行や経営参画への意識を高めるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Introduction of a Long-Term Incentive Stock Compensation Plan for Employees of U.S. Subsidiary Deciphera Pharmaceuticals, Inc. | ONO PHARMACEUTICAL CO.,LTD. (4528) timely disclosure | Komori